表紙
市場調査レポート

血糖自己測定器の世界市場:2015年〜2019年

Global Self-monitoring Blood Glucose Devices Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 338514
出版日 ページ情報 英文 60 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
血糖自己測定器の世界市場:2015年〜2019年 Global Self-monitoring Blood Glucose Devices Market 2015-2019
出版日: 2015年08月26日 ページ情報: 英文 60 Pages
概要

世界における血糖自己測定器市場は、2014年から2019年の間、10.47%のCAGRで拡大することが予測されています。

当レポートでは、世界における血糖自己測定器市場の現状と将来予測をコンポーネントのタイプ別、地域別に提供しており、市場の成長因子と課題、主な動向、主要ベンダーの分析などとともにお届けします。

第1章 エグゼクティブサマリー

  • 概況

第2章 当レポートの調査範囲

  • 市場概要
  • 主要ベンダーの製品 (サービス)

第3章 市場調査手法

  • 調査手法
  • 経済指標

第4章 イントロダクション

  • 主な市場概況

第5章 血糖自己測定器の概要

  • 背景
  • 定義
  • 糖尿病の合併症

第6章 罹患率と有病率

第7章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第8章 血糖自己測定器のコンポーネントタイプ別市場分類

  • 血糖検査ストリップ
  • ランセット
  • 血糖値計

第9章 地理区分

  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域

第10章 市場成長因子

第11章 市場成長因子の影響

第12章 市場の課題

第13章 成長因子と課題の影響

第14章 市場動向

第15章 ベンダー情勢

  • 競合シナリオ
  • 市場シェア分析
  • その他の有力ベンダー

第16章 主要ベンダーの分析

  • Abbott Diagnostics
  • Bayer Healthcare
  • LifeScan
  • Roche Diagnostics

第17章 付録

  • 略語リスト

第18章 Technavioについて

目次
Product Code: IRTNTR7007

About self-monitoring blood glucose device

Self-monitoring blood glucose device is a home-based electronic device. It consists of a glucose sensor and a transmitter that transmits information about glucose levels through radiowaves from the sensor to a receiver, where it is displayed. The regular usage of self-monitoring blood glucose devices can improve self-management of diabetes and prompt an individual to undergo proper diabetes treatment.

Technavio's analysts forecast the global self-monitoring blood glucose devices market to grow at a CAGR of 10.47% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global self-monitoring blood glucose devices market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of self-monitoring blood glucose devices.

Technavio's report, Global Self-monitoring Blood Glucose Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Abbott Laboratories
  • Arkray
  • Bayer Healthcare
  • LifeScan
  • Roche Diagnostics

Other Prominent Vendors

  • Animas
  • B. Braun Melsungen
  • Bionime
  • Bioptik Technology
  • Chongqing Haray International Business
  • Dexcom
  • Gluco-Ease
  • LabStyle Innovations
  • Integrity Applications
  • M Pharmaceutical
  • Medtronic
  • Medisana
  • Nipro Diagnostics
  • Nova Biomedical
  • OrSense
  • Sunrising Enterprise
  • Tekcapital
  • Grove Instruments
  • Wuhan HNC Technology

Market driver

  • Growing aging population
  • For a full, detailed list, view our report

Market challenge

  • High cost
  • For a full, detailed list, view our report

Market trend

  • Increasing adoption of home healthcare devices
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: SMBG: An overview

  • Background
  • Definition
  • Complications of diabetes

PART 06: Incidence and prevalence

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by type of SMBG components

  • Global blood glucose test strips market
  • Global lancets market
  • Global blood glucose meters market

PART 09: Geographical segmentation

  • SMBG devices market in Americas
  • SMBG devices market in EMEA
  • SMBG devices market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key Vendor Analysis

  • Abbott Diagnostics
  • Bayer Healthcare
  • LifeScan
  • Roche Diagnostics

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Categorization of SMBG devices by generation
  • Exhibit 03: Distribution channel overview of SMBG devices
  • Exhibit 04: Prevalence of diabetes 2013
  • Exhibit 05: Prevalence of diabetes 2013
  • Exhibit 06: Various treatment methods for diabetes management (%)
  • Exhibit 07: Global SMBG devices market 2014-2019 ($ billions)
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Global SMBG devices market segmentation by components
  • Exhibit 10: SMBG meters segmentation 2014
  • Exhibit 11: Global SMBG devices market segmentation by components 2014
  • Exhibit 12: Global blood glucose test strips market 2014-2019 ($ billions)
  • Exhibit 13: Global lancets market 2014-2019 ($ billions)
  • Exhibit 14: Global blood glucose meters market 2014-2019 ($ billions)
  • Exhibit 15: Global SMBG devices market segmentation by components 2014-2019 ($ billions)
  • Exhibit 16: Global SMBG devices market segmentation by components 2014-2019
  • Exhibit 17: Global SMBG devices market segmentation by geography 2014-2019
  • Exhibit 18: SMBG devices market in Americas 2014-2019 ($ billions)
  • Exhibit 19: SMBG devices market in EMEA 2014-2019 ($ billions)
  • Exhibit 20: SMBG devices market in APAC 2014-2019 ($ billions)
  • Exhibit 21: SMBG devices market segmentation by geography 2014-2019 ($ billions)
  • Exhibit 22: Global SMBG devices market segmentation by geography 2014-2019
  • Exhibit 23: Impact of drivers
  • Exhibit 24: Impact of drivers and challenges
  • Exhibit 25: Market share analysis of top vendors 2014
  • Exhibit 26: Abbott Diagnostics: Key takeaways
  • Exhibit 27: Bayer Healthcare: Key takeaways
  • Exhibit 28: LifeScan: Key takeaways
  • Exhibit 29: Roche: Key takeaways
  • Exhibit 30: Abbott Diagnostics: Key business offerings
Back to Top